{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:13:45Z","timestamp":1759364025832,"version":"build-2065373602"},"reference-count":19,"publisher":"AACN Publishing","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,1]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Many patients with end-stage kidney disease begin dialysis therapy with central venous dialysis catheters, significantly increasing the risk of dialysis catheter\u2013related bloodstream infection. Bloodstream infections are among the most severe harm events affecting patients receiving dialysis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Local Problem<\/jats:title>\n                  <jats:p>In 2023, the dialysis catheter\u2013related central line [catheter]\u2013associated bloodstream infection (CLABSI) rate at an acute care medical center in southern California was thrice the national benchmark. This quality improvement project aimed to decrease this rate by adding chlorhexidine-coated dialysis catheter caps to standard care.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Using the Knowledge to Action model, the medical center made a dialysis catheter\u2013related CLABSI reduction practice change. Preimplementation and postimplementation monthly aggregate data were collected for dialysis catheter\u2013related CLABSIs, central venous dialysis catheter days, and dialysis catheter\u2013related infection rates. One-on-one dialysis staff simulation training and process compliance audits ensured intervention fidelity. The intervention was replacement of nonchlorhexidine dialysis catheter caps with chlorhexidine-coated dialysis catheter caps for patients with central venous dialysis catheters.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>An 8-week preimplementation period included 119 patients, 561 dialysis therapies, 934 central dialysis catheter days, and 2 dialysis catheter\u2013related CLABSIs (2.14 infections per 1000 catheter days). An 8-week postimplementation period included 128 patients, 583 dialysis therapies, 897 central dialysis catheter days, and 0 dialysis catheter\u2013related CLABSIs; no dialysis catheter\u2013related CLABSIs occurred during postimplementation sustainability assessment (24 weeks total).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Use of chlorhexidine-coated dialysis catheter caps led to clinically significant results among patients receiving dialysis with central catheters at an acute care medical center.<\/jats:p>\n               <\/jats:sec>","DOI":"10.4037\/ccn2025293","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:03:10Z","timestamp":1759276990000},"page":"53-62","source":"Crossref","is-referenced-by-count":0,"title":["Using Chlorhexidine-Coated Dialysis Catheter Caps to Reduce Central Venous Dialysis Catheter Infection Rates: A Quality Improvement Project"],"prefix":"10.4037","volume":"45","author":[{"given":"Rosemary","family":"Olivier","sequence":"first","affiliation":[{"name":"Rosemary Olivier is a critical care clinical coordinator at Providence St. Jude Medical Center, Fullerton, California."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Skinner","sequence":"additional","affiliation":[{"name":"Claudia Skinner is the senior manager of epidemiology and infection control in the Infection Prevention Department at Providence St. Jude Medical Center."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd","family":"Bloom","sequence":"additional","affiliation":[{"name":"Todd Bloom is an infection preventionist in the Infection Prevention Department at Providence St. Jude Medical Center."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dana","family":"Rutledge","sequence":"additional","affiliation":[{"name":"Dana Rutledge is a nursing research facilitator\/consultant, Orange County, California."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2471","reference":[{"issue":"4","key":"2025093020024817500_b1-0450053","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1681\/ASN.2017080870","article-title":"Cluster-randomized trial of devices to prevent catheter-related bloodstream infection","volume":"29","author":"Brunelli","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"2025093020024817500_b2-0450053","doi-asserted-by":"publisher","first-page":"429","DOI":"10.2215\/CJN.11360821","article-title":"Catheter-associated bloodstream infections among patients on hemodialysis: progress before and during COVID-19 pandemic","volume":"17","author":"Johansen","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"2025093020024817500_b3-0450053","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1053\/j.ajkd.2016.09.014","article-title":"Dialysis catheter-related bloodstream infections: a cluster-randomized trial of the ClearGuard HD antimicrobial barrier cap","volume":"69","author":"Hymes","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"2025093020024817500_b4-0450053","doi-asserted-by":"publisher","first-page":"125","DOI":"10.2147\/IJNRD.S304605","article-title":"Evaluating a novel hemodialysis central venous catheter cap in reducing bloodstream infections: a quality improvement initiative","volume":"14","author":"Weiss","year":"2021","journal-title":"Int J Nephrol Renovasc Dis"},{"issue":"5","key":"2025093020024817500_b5-0450053","doi-asserted-by":"publisher","first-page":"151467","DOI":"10.1016\/j.semnephrol.2023.151467","article-title":"Strategies to prevent infections in dialysis patients","volume":"43","author":"Ponce","year":"2023","journal-title":"Semin Nephrol"},{"issue":"1","key":"2025093020024817500_b6-0450053","doi-asserted-by":"publisher","first-page":"132","DOI":"10.2215\/CJN.06820619","article-title":"Prevention of bloodstream infections in patients undergoing hemodialysis","volume":"15","author":"Fisher","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"2025093020024817500_b7-0450053","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1017\/ice.2022.87","article-title":"Strategies to prevent central line-associated bloodstream infections in acute-care hospitals: 2022 update","volume":"43","author":"Buetti","year":"2022","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"4","key":"2025093020024817500_b8-0450053","doi-asserted-by":"publisher","first-page":"CD010597","DOI":"10.1002\/14651858.CD010597.pub2","article-title":"Antimicrobial lock solutions for preventing catheter-related infections in haemodialysis","volume":"4","author":"Arechabala","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"2025093020024817500_b9-0450053","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.ajic.2022.09.005","article-title":"Antiseptic barrier caps to prevent central line-associated bloodstream infections: a systematic review and meta-analysis","volume":"51","author":"Gillis","year":"2022","journal-title":"Am J Infect Control"},{"issue":"1","key":"2025093020024817500_b10-0450053","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s12879-019-3848-z","article-title":"Educational interventions alone and combined with port protector reduce the rate of central venous catheter infection and colonization in respiratory semi-intensive care unit","volume":"19","author":"Inchingolo","year":"2019","journal-title":"BMC Infect Dis"},{"issue":"4 suppl 2","key":"2025093020024817500_b11-0450053","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1053\/j.ajkd.2019.12.001","article-title":"KDOQI clinical practice guideline for vascular access: 2019 update","volume":"75","author":"Lok","year":"2020","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"2025093020024817500_b12-0450053","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.ijantimicag.2017.06.013","article-title":"Systematic review of antimicrobial lock therapy for prevention of central-line-associated bloodstream infections in adult and pediatric cancer patients","volume":"50","author":"Norris","year":"2017","journal-title":"Int J Antimicrob Agents"},{"issue":"14","key":"2025093020024817500_b13-0450053","doi-asserted-by":"publisher","first-page":"S36","DOI":"10.12968\/bjon.2022.31.14.S36","article-title":"Chlorhexidine (di) gluconate locking device for central line infection prevention in intensive care unit patients: a multi-unit, pilot randomized controlled trial","volume":"31","author":"Pook","year":"2022","journal-title":"Br J Nurs"},{"key":"2025093020024817500_b14-0450053","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ijnurstu.2017.01.007","article-title":"Antiseptic barrier cap effective in reducing central line-associated bloodstream infections: a systematic review and meta-analysis","volume":"69","author":"Voor in \u2019t holt","year":"2017","journal-title":"Int J Nurs"},{"key":"2025093020024817500_b15-0450053","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ejim.2022.01.040","article-title":"Antiseptic barrier caps in central line-associated bloodstream infections: a systematic review and meta-analysis","volume":"99","author":"Tejada","year":"2022","journal-title":"Eur J Intern Med"},{"issue":"7","key":"2025093020024817500_b16-0450053","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.2215\/CJN.11411116","article-title":"National Healthcare Safety Network (NHSN) dialysis event surveillance report for 2014","volume":"12","author":"Nguyen","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"2025093020024817500_b17-0450053","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/chp.47","article-title":"Lost in knowledge translation: time for a map?","volume":"26","author":"Graham","year":"2006","journal-title":"J Contin Educ Health Prof"},{"key":"2025093020024817500_b18-0450053","doi-asserted-by":"publisher","first-page":"103497","DOI":"10.1016\/j.jdent.2020.103497","article-title":"Current use of chlorhexidine for management of oral disease: a narrative review","volume":"103","author":"Brookes","year":"2020","journal-title":"J Dent"},{"issue":"10","key":"2025093020024817500_b19-0450053","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.3390\/antibiotics10101192","article-title":"Effect of chlorhexidine digluconate in early wound healing of human gingival tissues. A histological, immunohistochemical and biomolecular analysis","volume":"10","author":"Pilloni","year":"2021","journal-title":"Antibiotics (Basel)"}],"container-title":["Critical Care Nurse"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacnjournals.org\/ccnonline\/article-pdf\/45\/5\/53\/166002\/53.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacnjournals.org\/ccnonline\/article-pdf\/45\/5\/53\/166002\/53.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:03:11Z","timestamp":1759276991000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacnjournals.org\/ccnonline\/article\/45\/5\/53\/32844\/Using-Chlorhexidine-Coated-Dialysis-Catheter-Caps"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10,1]]}},"URL":"https:\/\/doi.org\/10.4037\/ccn2025293","relation":{},"ISSN":["0279-5442","1940-8250"],"issn-type":[{"value":"0279-5442","type":"print"},{"value":"1940-8250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,1]]}}}